July 2018: A Message from the President
The nature of associations is to change. Change is a necessity in an advancing field like ours, but for an association, it’s needed to stay ahead of the curve, exceed expectations and carve new paths for their audience. The field of blood and marrow transplantation itself wouldn’t be around if it weren’t for change — changing technologies, research and innovation all led to the formation of this field and the initial group of clinicians and researchers that became the foundation for ASBMT.
July 2018: Policy Perspective
June was deadline month – the CMS NCA for CAR-T, the IPPS rule and several presentation due dates on top of it all. On June 14, we held our second Town Hall session — these are more informal opportunities for me to connect with members on key health policy issues that come up. I would welcome your feedback, as we plan to hold more of these Town Hall events as other important matters come about for ASBMT members.
FACT Update: July 2018
Study Compares Standards and Accreditation
A comparison of cord blood banking standards and voluntary accreditations has been completed by the Cord Blood Association (CBA) Quality Standards Committee.
The committee’s report is the result of an extensive review and analysis of banking standards, as well as questions posed to AABB and the Foundation for the Accreditation of Cellular Therapy (FACT).
2018 BMT Tandem Meetings: Session Recordings Now Available!
All session recordings from the 2018 BMT Tandem Meetings are available! Registered attendees can purchase and download available recordings for a flat fee. Were you not able to join us in Salt Lake City? Not to worry; non-attendees can purchase individual sessions as well.
Follow the below instructions for accessing the recordings based on your registration for the 2018 Tandem Meetings. If you have any questions or issues, please reach out to the Conference Office at TCTMeetings@mcw.edu.
July 2018: Association News
ASBMT Selects Andre Williams as New Executive Director
ASBMT is pleased to announce that we have completed the selection process for ASBMT's new executive director. Following a thoughtful review process, ASBMT leadership has unanimously selected Andre Williams to serve as executive director effective July 1.
Andre brings substantial knowledge, skills, and experience to ASBMT from his career serving as executive director of both clinician and translational science organizations.